GCISAVE: A Non-Comparative Randomized Phase II Study of Combination of Gemcitabine Cisplatin (gcis) +/- Avelumab (A) in 1st Line Treatment for Locally Advanced or Metastatic Urothelial Bladder Carcinoma (MUBC)—GETUG AFU V07.
Journal of Clinical Oncology（2024）
关键词
261-566-9718-9794,261-492-2769,613-135-244-3829,261-492-5651-9270,3590,176,1880,62,1880,242,295
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要